Skip to main content
Equibles
GILD logo

GILD · Gilead Sciences, Inc. · Analyst Estimates

Track GILD — free

Use GILD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GILD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$156.04 -1.15 (-0.73%) At close · Oct 23
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$193.48B
Shares
1.24B
Volume · Oct 23 6.07M Avg daily vol (3M) 6.07M

Analyst Estimates

Compare analyst forecasts for Gilead Sciences, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-24 08:56 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.09
-0.43
-0.02
27
-0.40
-0.43
-0.42
-0.77
1
1
5
6
Revenue
USD
Publication date not stated
30.47B
30.78B
31.45B
25
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
9.19
9.97
11.44
26
9.94
9.89
9.89
9.63
2
2
5
5
Revenue
USD
Publication date not stated
31.92B
32.90B
34.11B
24
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.99
2.21
2.68
22
2.20
2.15
2.15
2.20
2
2
5
5
Revenue
USD
Publication date not stated
7.66B
7.81B
7.98B
20
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.29
2.12
3.13
20
2.17
2.19
2.19
2.25
4
4
3
3
Revenue
USD
Publication date not stated
8.01B
8.20B
8.84B
17
 — — — — — — — —
Key facts CIK 882095 CUSIP 375558103 13F (30d) 693 filings 673 filers Visit website Investor relations